Why the study?
Does the lack of A1 adenosine receptors augment diabetic hyperfiltration and glomerular injury in diabetic mice?
Does the lack of A1 adenosine receptors augment diabetic hyperfiltration and glomerular injury in diabetic mice?
Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury, indicating that an A1AR-dependent mechanism limits the degree of diabetic nephropathy.
Answers are grounded in this paper and cite their sources.
A1AR deletion augments hyperfiltration and injury in diabetic mice; hypothesis-generating for A1AR modulation in human diabetic nephropathy.
Intraglomerular hypertension and glomerular hyperfiltration likely contribute to the pathogenesis of diabetic nephropathy, and tubuloglomerular feedback (TGF) has been suggested to play a role in diabetic hyperfiltration. A1 adenosine receptor (A1AR) null mice lack a TGF response, so this model was used to investigate the contribution of TGF to hyperfiltration in diabetic Ins2(+/-) Akita mice. TGF responses in Ins2(+/-) A1AR(-/-) double mutants were abolished, whereas they were attenuated in Ins2(+/-) mice. GFR, assessed at 14, 24, and 33 wk, was approximately 30% higher in Ins2(+/-) than in wild-type (WT) mice and increased further in Ins2(+/-) A1AR(-/-) mutants (P < 0.01 versus both WT and Ins2(+/-) mice at all ages). Histologic evidence of glomerular injury and urinary albumin excretion were more pronounced in double-mutant than single-mutant or WT mice. In summary, the marked elevation of GFR in diabetic mice that lack a TGF response indicates that TGF is not required to cause hyperfiltration in the Akita model of diabetes. Rather, an A1AR-dependent mechanism, possibly TGF, limits the degree of diabetic hyperfiltration and nephropathy.
No takes yet. Share an insight, caveat, or question.
Faulhaber‐Walter et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: